共 50 条
Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'
被引:4
|作者:
Wehrle, Chase J.
[1
]
Fujiki, Masato
[1
]
Schlegel, Andrea
[1
]
Whitsett Linganna, Maureen
[1
]
Pita, Alejandro
[1
]
Kim, Jae-Keun
[1
]
Kwon, David C. H.
[1
]
Miller, Charles
[1
]
Hashimoto, Koji
[1
]
Dueland, Svein
[2
]
Sasaki, Kazunari
[3
]
Sapisochin, Gonzalo
[4
]
Line, Pal-Dag
[2
]
Hernandez-Alejandro, Roberto
[5
]
Aucejo, Federico
[1
]
机构:
[1] Cleveland Clin Fdn, Dept Liver Transplantat, Cleveland, OH 44195 USA
[2] Oslo Univ Hosp, Dept Transplantat, Oslo, Norway
[3] Stanford Univ, Dept Abdominal Transplantat, Palo Alto, CA USA
[4] Univ Toronto, Toronto Gen Hosp, Dept Abdominal Transplant & HPB Surg Oncol, Toronto, ON, Canada
[5] Univ Rochester, Dept Liver Transplantat, Med Ctr, Rochester, NY USA
关键词:
D O I:
10.1245/s10434-023-14611-z
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Colorectal cancer is the second most common cause of cancer-related death worldwide, and half of patients present with colorectal liver metastasis (CRLM). Liver transplant (LT) has emerged as a treatment modality for otherwise unresectable CRLM. Since the publication of the Lebeck-Lee systematic review in 2022, additional evidence has come to light supporting LT for CRLM in highly selected patients. This includes reports of >10-year follow-up with over 80% survival rates in low-risk patients. As these updated reports have significantly changed our collective knowledge, this article is intended to serve as an update to the 2022 systematic review to include the most up-to-date evidence on the subject.
引用
收藏
页码:1148 / 1170
页数:23
相关论文